GMP Cytokines Market is expected to reach US$ 158.13 Million by 2027

PRESS RELEASE BY The Insight Partners 29 Jan 2021

Share this press on

The GMP cytokines market size is expected to reach US$ 158.13 million in 2027 and registering at a CAGR of 8.1% from 2020 to 2027, according to a new research study conducted by The Insight Partners.


TNF Segment by Type is Expected to Witness Rapid Growth During Forecast Period


The report highlights trends prevailing in the global GMP cytokines market and factors governing the market growth.


Based on type, the growth factors segment held the largest share of the market in 2019; whereas, the TNF segment is expected to grow at the fastest CAGR during the forecast period. TNF-α is cytotoxic to a wide range of tumor cells, and is a vital factor in stimulating immune response against bacterial infections. Increasing prevalence of cancer and infectious diseases is likely to propel the growth of the segment. Additionally, an extensive research study on TNF is likely to favor the growth of the segment during the forecast period. For instance, ‘Nonconventional induction strategies for production of recombinant human tumor necrosis factor-alpha in Escherichia coli’ was published in 2018.


The growth of the GMP cytokines market is mainly attributed to the increase in acceptance of cytokines cancer and autoimmune therapies and potential contribution in the stem cell therapy. However, high cost associated with GMP cytokines therapy is projected to deter the market growth.


Miltenyi Biotec; Sino Biological Inc.; ABCAM; PeproTech Inc.; Akron Biotech; CellGenix GmbH; BIO-TECHNE CORPORATION; CREATIVE BIOARRAY; Proteintech Group, Inc.; and REPROCELL Inc. are among the leading companies operating in the GMP cytokines market.


GMP Cytokines Market , by Region, 2019 (%)

GMP Cytokines Market , by Region, 2019 (%)

GMP Cytokines Market Size, Statistics Report 2022, 2027

Download Free Sample

Published Report - GMP Cytokines Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (TNF, Interleukins, Growth Factors, and Others), and Application (Cell and Gene Therapy, Tissue- Engineered Products, and Others), and Geography


The report segments global GMP cytokines market as follows:


By Type

  • TNF
  • Interleukin
  • Growth Factor
  • Others

By Application

  • Cell and Gene Therapy
  • Tissue-Engineered Products
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East and Africa (MEA)
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East and Africa
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of South and Central America

Contact Us
Phone: +1-646-491-9876
Email Id:   

Download Free PDF Brochure